scholarly journals Quantitative profiling of innate immune activation by viral infection in single cells

2017 ◽  
Vol 9 (9) ◽  
pp. 782-791 ◽  
Author(s):  
Andrea C. Timm ◽  
Jay W. Warrick ◽  
John Yin

We have identified critical aspects of the competition between a virus and its host's immune-response, within single-cells using fluorescent reporters.

2021 ◽  
Author(s):  
Andrew Beppu ◽  
Juanjuan Zhao ◽  
Changfu Yao ◽  
Gianni Carraro ◽  
Edo Israely ◽  
...  

Summary: Epithelial plasticity has been suggested in lungs of mice following genetic depletion of stem cells but is of unknown physiological relevance. Viral infection and chronic lung disease share similar pathological features of stem cell loss in alveoli, basal cell (BC) hyperplasia in small airways, and innate immune activation, that contribute to epithelial remodeling and loss of lung function. We show that a novel lineage of distal airway secretory cells, intralobar serous (IS) cells, are activated to assume BC fates following influenza virus infection. Nascent BC differ from pre-existing BC by high expression of IL-22ra1 and undergo IL-22-dependent expansion for colonization of injured alveoli. Resolution of virus-elicited inflammation resulted in BC>IS re-differentiation in repopulated alveoli, and increased local expression of antimicrobial factors, but failed to replace normal alveolar epithelium. Epithelial plasticity therefore protects against mortality from acute respiratory viral infection but results in distal lung remodeling and loss of lung function.


2022 ◽  
Author(s):  
Amrita Cheema ◽  
Yaoxiang Li ◽  
Sean Collins ◽  
Simeng Suy ◽  
Mary Ventimiglia ◽  
...  

Stereotactic body radiation therapy (SBRT) is a curative therapeutic modality employing large fractional doses of highly conformal radiation therapy for cancer treatment. To understand the mechanisms underlying clinical responses to radiation therapy, SBRT offers a unique window for high-throughput analysis of post-radiation molecular events to inform predictive biomarker discovery and strategies for multi-disciplinary therapeutics. We performed a longitudinal analysis of plasma proteins and metabolites from patients treated with prostate SBRT, comparing cohorts of patients in clinical remission to cohorts experiencing PSA-determined cancer progression. We observed the onset of post-SBRT DNA Damage Response (DDR), cell cycle arrest, and immune response signaling in patients within one hour of treatment and innate immune response signaling that persisted for up to three months following treatment. Furthermore, patients in remission experienced more robust immune responses and metabolite elevations consistent with a pro-inflammatory, M1-mediated innate immune activation in the short-term following SBRT, whereas patients with disease progression had less robust immune responses and M2-mediated metabolite elevations. We interpret these data to support a critical role for innate immune activation in the clinical outcomes of patients receiving radiation therapy for prostate cancer potentially improving future multidisciplinary therapeutic strategies.


2021 ◽  
Vol 29 (4) ◽  
pp. 1365-1366
Author(s):  
Robert Frederickson ◽  
Roland W. Herzog

Sign in / Sign up

Export Citation Format

Share Document